🔗 Visit the ClinicalTrials.gov page for NCT04212598
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Cancer statistics in China, 2015. | CA Cancer J Clin | 2016 | 12.92 |
| 2 | Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. | JAMA | 1999 | 7.86 |
| 3 | INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. | J Clin Oncol | 2002 | 6.74 |
| 4 | Cancer Statistics, 2017. | CA Cancer J Clin | 2017 | 4.77 |
| 5 | Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. | Int J Radiat Oncol Biol Phys | 2005 | 0.97 |
| 6 | High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II-III esophageal cancer. | Jpn J Clin Oncol | 2014 | 0.93 |